« Back to Record
Citation APA

Dumez, H., Awada, A., Piccart-Gebhart, M., Assadourian, S., Semiond, D., Guetens, G., De Boeck, G., Maes, R. A. A., de Bruijn, E. A., & van Oosterom, A. (2006). A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumours. Annals of oncology, 17(7), 1158-1165. doi:10.1093/annonc/mdl071


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/53744

Dumez, H., Awada, A., Piccart-Gebhart, M., Assadourian, S., Semiond, D., Guetens, G., De Boeck, G., Maes, R. A. A., de Bruijn, E. A., & van Oosterom, A. (2006). A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumours. Annals of oncology, 17(7), 1158-1165. doi:10.1093/annonc/mdl071